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Opinion
Three-dimensional power Doppler derived vascular indices: what are we measuring and
how are we doing it?
The role of Doppler in the assessment of fetal and
placental blood flow is well-established1. However, as
exemplified by the large variability of results published
in the literature, its role in the evaluation of uterine
and ovarian hemodynamics is not so clearly defined.
Velocimetric indices such as pulsatility index and
resistance index have been shown to provide useful
information on uterine perfusion and angiogenesis in the
ovarian follicle and certain cancers, but have not been
adopted to any significant degree into clinical practice.
Because of the advantages of power Doppler compared
with conventional two-dimensional color Doppler2, some
investigators have advocated its use for blood flow
mapping3,4. However, this technique only provides
information on the ‘vascular map’ of a given region of
interest and assessment relies largely on the subjective
impression of the examiner.
The advent of three-dimensional (3D) power Doppler
ultrasound has begun a new era in tissue and organ
vascularization research. Using this technique, we can
now assess a virtually reconstructed vascular tree within
a volume of interest5 and can ‘objectively’ determine its
vascularization by calculating indices using the specially
designed VOCAL
TM
software (GE Medical Systems, Zipf,
Austria)6. Objective and non-invasive quantification of
vascularization of a given tissue volume holds much
promise, particularly because this method has proved
to be highly reproducible between observers (thereby
overcoming one of the main limitations of conventional
Doppler ultrasound)7–9.
Since the pioneering study of Pairleitner et al.6 in
1999, more than 100 papers have been published ana-
lyzing the role of 3D power Doppler ultrasound in
almost all areas of obstetrics and gynecology, includ-
ing placental and fetal vascularization10,11, reproductive
medicine12,13, gynecological endocrinology14, gynecolog-
ical oncology15–17, breast pathology18 and the pelvic
floor19.
Despite this abundance of literature on the application
of 3D power Doppler ultrasound, it seems that so far few
have stopped to ask what we are measuring. Calculation
of the three 3D power Doppler ultrasound vascular
indices, the vascularization index (VI), flow index (FI)
and vascularization flow index (VFI), is based on and
related to the total and relative amounts of power Doppler
information within the volume of interest. VI denotes
the ratio of color-coded voxels to all voxels within the
volume and is expressed as a percentage, FI represents the
mean power Doppler signal intensity from all color-coded
voxels and VFI is the simple mathematical relationship
derived from multiplying VI by FI and dividing the result
by 1006. Both FI and VFI are unitless and are expressed as
a numerical value ranging from 0 to 100. The indices are
thought to reflect the number of vessels within the volume
of interest (VI), the intensity of flow at the time of the
3D sweep (FI), and both blood flow and vascularization
(VFI)6.
Although our knowledge about what these indices are
actually measuring is limited, most examiners involved
with the use of power Doppler are aware that several
factors affect the power Doppler signal20,21. Yet, studies
evaluating how machine settings affect measurements are
scanty22. In this issue of the Journal, three papers make a
significant contribution to the understanding of what these
indices are measuring and how machine settings affect the
measurements23–25. All three studies were performed in
an in-vitro setting using a flow phantom experiment.
In the first study by Raine-Fenning et al.23, the authors
evaluated the relationship of VI, FI and VFI values with
vessel number, flow rate, attenuation and ‘erythrocyte’
density. They found a positive linear relationship between
VI and VFI and all these factors except attenuation,
which showed a negative relationship. In other words,
with increasing number of vessels, volume flow or
erythrocyte density, VI and VFI values increase. In the
case of VI, these findings are particularly interesting.
VI actually quantifies the number of color-coded voxels,
which does not necessarily mean the number of vessels.
However, in this phantom study, the authors found a
correlation between the number of color-coded voxels
and ‘number of vessels’. This finding is in agreement with
preliminary data from in-vivo studies that showed that
VI correlates positively with microvessel density count
as assessed by immunohistochemical techniques26. In
contrast, the further the object under investigation is
from the transducer, the lower the values obtained. This
is of clinical relevance, because the route – transvaginal
or transabdominal – should be taken into account when
performing the calculations, as should the distance
between the probe and the object under investigation.
However, Raine-Fenning et al. found that FI showed
a ‘more complex cubic relationship that is not always
logical’. This could indicate that FI is less predictable than
VI and VFI. For example, they discovered that VI and VFI
increase steadily with an increasing number of vessels,
while FI reached a peak with three vessels and decreased
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thereafter. Additionally, as the authors themselves proved,
a greater distance from the transducer to the furthest
‘vessels’ in the phantom decreased the signal intensity,
leading to an overall decrease of the power Doppler
signal.
In their second paper, Raine-Fenning et al.24 demon-
strate that machine settings and speed of acquisition
affect significantly all three 3D power Doppler ultrasound
indices. These findings could be anticipated because it
is well known that machine settings affect the power
Doppler signal20,21. A potential weakness of their study is
that it used an ultrasound machine from the old Voluson
series, the Voluson 530, which did not have the power
Doppler sensitivity of equipment in current use. However,
in my opinion, this fact does not invalidate their results.
In fact, in the third study, by Schulten-Wijman et al.25,
the more modern Voluson 730 Expert was used and the
principal study findings, that machine settings affect VI
and FI calculation, were similar. An interesting additional
finding is that ‘measured VI’ overestimated ‘actual VI’
even with different machine settings by up to 44 times!
The concept of ‘actual VI’, as described by the authors
in the paper, could be misleading but they are probably
right. The VI is just a ratio between colored and total
voxels and, since voxels are actually small cubes that
occupy a predetermined volume, in my opinion, the VI
is in fact the ratio between the volume of colored vox-
els and the volume of the total voxels. However, what
I cannot understand is how they obtained those results
because, assuming that all colored voxels within the tube
are detected by the machine, the VI should be as high as
the ‘actual VI’, but never higher. The experimental set-up
in this study used a single tube, simulating one vessel, and
it remains to be seen whether this finding could be extrap-
olated to true tissue vascularization where multiple vessels
exist. Notwithstanding, this fact should be taken into con-
sideration when measuring the VI in a single vessel, such
as the uterine, umbilical, or fetal middle cerebral artery.
Schulten-Wijman et al. also propose that the term ‘flow
index’ be replaced by ‘power index’, a suggestion that I
would endorse, because what we are actually measuring
is mean power Doppler signal intensity.
Although it should be acknowledged that phantom
studies for assessing Doppler systems have certain
limitations27,28, and that the authors of these three studies
used somewhat exaggerated machine settings that are
not usually used in clinical practice, the results they
report are relevant for at least two reasons. First, they
provide evidence that machine settings affect VI, FI and
VFI calculations. The primary consequence of this should
be that all future papers published using this method
should report the machine settings used and even the
maximum depth of the objects evaluated when performing
investigations. Furthermore, these results should prompt
us to reach a consensus about which machine settings
should be used, at least in the research situation, in order
to allow meaningful comparison among studies. To the
best of my knowledge, only the 3D Ultrasound Group
from the Spanish Society of Ultrasound in Obstetrics
and Gynecology has documented recommendations about
machine settings to be used for research29 and, in
my opinion, the International Society of Ultrasound in
Obstetrics and Gynecology (ISUOG) should formulate a
proposal for standardized settings to be used worldwide.
Second, these studies have shown how VI, FI and VFI
indices are not related equally to the number of vessels and
volume flow. This implies that the most appropriate index
to use might be different depending on the clinical setting.
For example, for analyzing tumor vascularization, VI may
be preferred because in clinical practice oncologists and
pathologists already use the mean vessel density (i.e. the
number of vessels as a measure of tumor vascularization),
the amount of flow being less relevant. However, when
volume flow is the target of investigation, for example in
maternal–fetal and reproductive medicine, it may be that
FI is more useful.
I believe that we are a long way from clearly defining
the role of 3D power Doppler ultrasound indices in
clinical practice. However, steps such as those reported
in this issue of the Journal are important for the scientific
understanding of this technology.
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